446 The administration of JAK and TYK2 inhibitor successfully ameliorated the severity of T cell transfer-induced colitis in mice
- DOI
- 10.1136/jitc-2023-sitc2023.0446
- Published
- November
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2023-sitc2023.0446,
title = {446 The administration of JAK and TYK2 inhibitor successfully ameliorated the severity of T cell transfer-induced colitis in mice},
author = {Juan Wang and Chunhui He and Nan Xie and Ruiqing Yan and Xiangnan Qiang and Yanping Yuan and Dongye Jia},
year = {2023},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2023-sitc2023.0446},
url = {https://doi.org/10.1136/jitc-2023-sitc2023.0446}
}RIS
TY - JOUR TI - 446 The administration of JAK and TYK2 inhibitor successfully ameliorated the severity of T cell transfer-induced colitis in mice AU - Juan Wang AU - Chunhui He AU - Nan Xie AU - Ruiqing Yan AU - Xiangnan Qiang AU - Yanping Yuan AU - Dongye Jia PY - 2023 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2023-sitc2023.0446 UR - https://doi.org/10.1136/jitc-2023-sitc2023.0446 ER -
APA
Wang, J., He, C., Xie, N., Yan, R., Qiang, X., Yuan, Y., & Jia, D. (2023). 446 The administration of JAK and TYK2 inhibitor successfully ameliorated the severity of T cell transfer-induced colitis in mice. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-sitc2023.0446
Source records
- doaj · retrieved 2026-09-26T15:42:54.496Z